Teratogenic drugs - Part 2

Adverse Drug Reaction Bulletin

Volumn , Issue 214, 2002, Pages 819-822

  McElhatton, Patricia ^a  

^a Regional Drug Therapeutics Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CHEMICAL TERATOGEN; CIPROFLOXACIN; COUMARIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; LEFLUNOMIDE; METHOTREXATE; METHYLDOPA; MISOPROSTOL; NICOTINE; NORFLOXACIN; PHYTOMENADIONE; PROPYLTHIOURACIL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOL DERIVATIVE; TERATOGENIC AGENT; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; WARFARIN;

ABORTION; ANTIPHOSPHOLIPID SYNDROME; CANCER; CHILDHOOD CANCER; DOSE RESPONSE; DRUG ABUSE; DRUG BINDING; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; ECLAMPSIA; FETOTOXICITY; FETUS DISEASE; FOLIC ACID DEFICIENCY; HEART FAILURE; HUMAN; HYPERTENSION; INFECTION; MATERNAL DISEASE; NEWBORN DISEASE; NEWBORN HEMORRHAGIC DISEASE; PLACENTA DISORDER; PREGNANCY; PROPHYLAXIS; REVIEW; RHEUMATOID ARTHRITIS; TERATOGENICITY; THROMBOSIS; THYROTOXICOSIS; TOBACCO DEPENDENCE;

EID: 0036071777     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-200206000-00001     Document Type: Review

References (66)

1. CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9634 pregnant women
2. Preeclampsia prevention, lessons from the low-dose aspirin therapy trials
3. Anticoagulant and fibrinolytic drugs
4. Maternal and fetal sequelae of anticoagulation during pregnancy
5. Anticoagulants in pregnancy: Fetal effects
6. Fetal intraventricular haemorrhage and maternal warfarin
7. Safety of low-molecular-weight heparin in pregnancy: A systematic review
8. Low-molecular-weight heparin for thrombophilia in pregnant women
9. Anti-infective agents
10. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS)
11. Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study
12. Heart and circulatory system drugs
13. Diuretics
14. Neonatal head circumference and the treatment of maternal hypertension
15. Pharmacologic management of hypertension in pregnancy
16. Methyldopa hepatotoxicity in pregnancy: A case report
17. Risks and benefits of beta-receptor blockers for pregnancy hypertension: Overview of the randomized trials
18. Principles of teratogenesis applicable to drug and chemical exposure
19. Topical timolol therapy in pregnancy: Is it safe for the fetus?
20. Felodipine use in pregnancy. Report of three cases
21. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study
22. Nifedipine and ritodrine in the management of preterm labor: A randomized multicenter trial
23. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development
24. Losartan and fetal toxic effects
25. Angiotensin II-receptor inhibitors in pregnancy
26. Angiotensin II-receptor inhibitors in pregnancy
27. Angiotensin II-receptor inhibitors in pregnancy
28. Fetal toxic effects and angiotensin-II-receptor antagonists
29. Hormones
30. Treating thyrotoxicosis in pregnant and potentially pregnant women
31. Aplasia cutis congenita after exposure to methimazole: A causal relationship?
32. Methimazole, carbimazole and congenital skin defects
33. Methimazole embryopathy: Delineation of the phenotype
34. Teratogen update: Antithyroid drugs - Methimazole, carbimazole, and propylthiouracil
35. Neurobehavioral teratology of isotretinoin
36. Recommendations for isotretinoin use in women of childbearing potential
37. The negligible availability of retinoids with multiple and excessive topical application of isotretinoin 0.05% gel (Isotrex) in patients with acne vulgaris
38. Negligible systemic absorption of topical isotretinoin cream: Implications for teratogenicity
39. Transdermal absorption of topical anti-acne agents in man; A review of clinical pharmacokinetic data
40. Medical termination of pregnancy
41. The efficacy of medical abortion: A meta-analysis
42. Abortion with mifepristone and misoprostol: Regimens, efficacy, acceptability and future directions
43. Use of misoprostol in obstetrics and gynecology
44. Fetal malformation and failed medical termination of pregnancy
45. Use of misoprostol during pregnancy and Möbius' syndrome in infants
46. Misoprostol embryotoxicity: Clinical evaluation of fifteen patients with arthrogryposis
47. Epidemiological assessment of misoprostol teratogenicity
48. Prenatal exposure to misoprostol and vascular disruption defects: A case-control study
49. Teratogenicity of misoprostol: Data from the Latin-American collaborative study of congenital malformations (ECLAMC)
50. Pregnancy outcome after exposure to misoprostol in Brazil: A prospective, controlled study
51. The effects of methotrexate in pregnancy, fertility and lactation
52. Methotrexate exposure prior to and during pregnancy
53. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome
54. Teratogen update: Reproductive risks of leflunomide (Arava™); a pyrimidine synthesis inhibitor: Counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child
55. Recreational drugs
56. Fetal effects of maternal alcohol exposure
57. Diagnosing the full spectrum of fetal alcohol-exposed individuals: Introducing the 4-digit diagnostic code
58. Twelve-year follow-up of children exposed to alcohol in utero
59. On categorizations in analyses of alcohol teratogenesis
60. Relation to maternal age and pattern of pregnancy drinking to functionally significant cognitive deficit in infancy
61. Congenital anomalies after pre-natal ecstasy exposure
62. Zwangerschapsuitkomst na ecstacygebruik; 43 gevallen gevolgd donor de Teratologie Informatie Service van het RIVM
63. Fetal effects of substance abuse
64. Prenatal cocaine exposure and the expanding spectrum of brain malformations